4-OXO-3-[(PHENYLMETHYL)OXY]-4H-PYRAN-2-Carboxylic Acid
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 13/054,847, filed Apr 8, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,765,965 | 1-(2,3-Dihydroxypropyl)-4-OXO-3-[(PHENYLMETHYL)OXY]-1,4-Dihydro-2-Pyridinecarboxylic Acid of the Formula P-6 And/Or Methyl 1-(2,3-Dihydroxypropyl)-4-OXO-3-[(PHENYLMETHYL)OXY]-1,4-Dihydro-2-Pyridinecarboxylate of the Formula P-7 In force · High confidence | Shionogi & Co., Ltd. | In force | High confidence | ||
| US 8,940,912 | 4-OXO-3-[(PHENYLMETHYL)OXY]-4H-PYRAN-2-Carboxylic Acid In force · High confidence | Shionogi & Co., Ltd. | In force | High confidence | ||
| US 8,981,129 | 2-(2-Hydroxy-2-Phenylethyl)-3-[(PHENYLMETHYL)OXY]-4H-PYRAN-4-ONE of the Formula P-3 And/Or 2-[(E)-2-Phenylethenyl]-3-[(PHENYLMETHYL)OXY]-4H-PYRAN-4-ONE of the Formula P-4 In force · High confidence | Shionogi & Co., Ltd. | In force | High confidence | ||
| US 9,012,650 | SUBSTITUTED (3S, 11aR)-N-[(2,4-Difluorophenyl)METHYL]-6-OXY-3-Methyl-5,7-Dioxo-2,3,5,7,11,11a-HEXAHYDRO[1,3]OXAZOLO[3,2-a]PYRIDO[1,2-d]PYRAZINE-8-Carboxamides OF FORMULA (I) USEFUL AS HIV AGENTS In force · Medium confidence | Shionogi & Co., Ltd. | In force | Medium confidence | ||
| US 9,133,216 | (3S,11aR)-6-[(PHENYLMETHYL)OXY]-3-Methyl-2,3,11,11a-TETRAHYDROOXAZOLO[3,2-a]PYRIDO[1,2-d]PYRAZINE-5,7-Dione OF THE FORMULA P-9 AND/OR (3S,11aR)-6-[(PHENYLMETHYL)OXY]-8-Bromo-3-Methyl-2,3,11,11a-TETRAHYDROOXAZOLO[3,2-a]PYRIDO[1,2-d]PYRAZINE-5,7-Dione OF THE FORMULAP-10 In force · High confidence | Shionogi & Co., Ltd. | In force | High confidence | ||
| US 9,707,246 | Substituted (3S,11Ar)-n-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides as HIV Agents In force · High confidence | Shionogi & Co., Ltd. | In force | High confidence | ||
| US 8,580,967 | Methyl 3-(BENZYLOXY)-1-(2,2-Dihydroxyethyl)-4-OXO-1,4-Dihydropyridine-2-Carboxylate and Processes for the Preparation Thereof In force · High confidence | Viiv Healthcare Company | In force | High confidence |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Shionogi & Co., Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.